InsidersTradesSigma
Follow the 易明医药 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 易明医药 has published 4 insider filings. Market capitalisation: €3.1bn. The latest transaction was filed on 7 May 2025 (Sale). Among the most active insiders: 许可. The full history is free.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€193,405
4 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,772 of 29,063 companies
63.1
score / 100
Value44
Quality83
FCF yld3.8%
Earn yld3.0%
EV/EBITDA23.0x
ROE12%
Gross mgn82%
Net mgn15%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 May 2025
Acerca de 易明医药
易明医药 es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XSHE. Se enfoca en el desarrollo y la distribución de productos farmacéuticos innovadores.